Lymecycline is marketed by the company that became a subsidiary of what multinational in 2014?
Lymecycline: Lymecycline is a tetracycline broad-spectrum antibiotic marketed by the pharmaceutical company Galderma. Galderma: Galderma S.A. is a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments and became a wholly owned subsidiary of Nestlé in 2014.
Nestlé